ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Tourmaline Bio Inc

Tourmaline Bio Inc (TRML)

19.77
-0.91
( -4.40% )
Updated: 10:40:31

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
19.77
Bid
19.69
Ask
20.05
Volume
15,556
19.525 Day's Range 20.46
12.12 52 Week Range 48.31
Market Cap
Previous Close
20.68
Open
20.46
Last Trade
2
@
19.875
Last Trade Time
10:46:24
Financial Volume
$ 313,183
VWAP
20.1326
Average Volume (3m)
199,450
Shares Outstanding
25,642,610
Dividend Yield
-
PE Ratio
-12.16
Earnings Per Share (EPS)
-1.64
Revenue
-
Net Profit
-42.12M

About Tourmaline Bio Inc

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $20.68. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 12.12 to $ 48.31.

Tourmaline Bio currently has 25,642,610 shares outstanding. The market capitalization of Tourmaline Bio is $530.29 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -12.16.

TRML Latest News

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

– Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of 2025 – – Deepak L. Bhatt, MD, MPH, MBA and Dipender Gill, MD...

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.88-4.2615012106520.6522.0719.52514708721.28447329CS
4-6.625-25.099450653526.39526.5919.1419017122.31608934CS
12-6.96-26.038159371526.7329.788319.1419945025.0089585CS
266.9153.73250388812.8629.788312.1219606421.80472662CS
52-6.41-24.484339190226.1848.3112.1228729822.96573823CS
1569.4591.569767441910.3248.319.1825858222.64522969CS
2609.4591.569767441910.3248.319.1825858222.64522969CS

TRML - Frequently Asked Questions (FAQ)

What is the current Tourmaline Bio share price?
The current share price of Tourmaline Bio is $ 19.77
How many Tourmaline Bio shares are in issue?
Tourmaline Bio has 25,642,610 shares in issue
What is the market cap of Tourmaline Bio?
The market capitalisation of Tourmaline Bio is USD 530.29M
What is the 1 year trading range for Tourmaline Bio share price?
Tourmaline Bio has traded in the range of $ 12.12 to $ 48.31 during the past year
What is the PE ratio of Tourmaline Bio?
The price to earnings ratio of Tourmaline Bio is -12.16
What is the reporting currency for Tourmaline Bio?
Tourmaline Bio reports financial results in USD
What is the latest annual profit for Tourmaline Bio?
The latest annual profit of Tourmaline Bio is USD -42.12M
What is the registered address of Tourmaline Bio?
The registered address for Tourmaline Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Tourmaline Bio website address?
The website address for Tourmaline Bio is talaristx.com
Which industry sector does Tourmaline Bio operate in?
Tourmaline Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WATTEnergous Corporation
$ 1.8994
(361.92%)
133.73M
NXUNXU Inc
$ 0.997301
(309.74%)
242.01M
INTZIntrusion Inc
$ 5.60
(159.26%)
96M
VINCVincerx Inc
$ 0.4184
(115.67%)
242.88M
AHGAkso Health Group
$ 1.9001
(69.65%)
2.45M
ABPAbpro Holdings Inc
$ 2.20
(-51.00%)
681.24k
TRAWTraws Pharma Inc
$ 8.10
(-39.64%)
757.09k
LITMSnow Lake Resources Ltd
$ 1.175
(-26.56%)
36.54M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
$ 66.14
(-25.24%)
6.73k
CISSC3is Inc
$ 0.5603
(-23.25%)
512.75k
VINCVincerx Inc
$ 0.4184
(115.67%)
242.55M
NXUNXU Inc
$ 0.997301
(309.74%)
238.55M
WATTEnergous Corporation
$ 1.8994
(361.92%)
132.99M
XTIAXTI Aerospace Inc
$ 0.04
(1.27%)
131.19M
INTZIntrusion Inc
$ 5.60
(159.26%)
94.5M

Your Recent History

Delayed Upgrade Clock